NO874241D0 - Terapeutisk aktive salter. - Google Patents

Terapeutisk aktive salter.

Info

Publication number: NO874241D0
Authority: NO; Norway
Prior art keywords: pct; therapeutic active; active salts; sec; date
Prior art date: 1986-02-12

Application number

NO874241A

Other languages

English (en)

Other versions

NO874241L (no

Inventor

Carlo Scolastico

Camillo Maria Franco G Palazzi

Original Assignee

S Team Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-02-12

Filing date

1987-10-09

Publication date

1987-10-09

1987-10-09 Application filed by S Team Srl filed Critical S Team Srl

1987-10-09 Publication of NO874241D0 publication Critical patent/NO874241D0/no

1987-12-09 Publication of NO874241L publication Critical patent/NO874241L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

NO874241A 1986-02-12 1987-10-09 Terapeutisk aktive salter. NO874241L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT8619382A IT1213034B (it)	1986-02-12	1986-02-12	Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
PCT/EP1987/000068 WO1987005024A1 (en)	1986-02-12	1987-02-12	Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base

Publications (2)

Publication Number	Publication Date
NO874241D0 true NO874241D0 (no)	1987-10-09
NO874241L NO874241L (no)	1987-12-09

Family

ID=11157215

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO874241A NO874241L (no)	1986-02-12	1987-10-09	Terapeutisk aktive salter.

Country Status (19)

Country	Link
US (1)	US4950776A (no)
EP (1)	EP0256069B1 (no)
JP (1)	JPH0780775B2 (no)
KR (1)	KR940011187B1 (no)
AT (1)	ATE71385T1 (no)
AU (1)	AU601403B2 (no)
CA (1)	CA1291766C (no)
DE (1)	DE3775854D1 (no)
DK (1)	DK169339B1 (no)
FI (1)	FI874450A (no)
HU (1)	HU199148B (no)
IE (1)	IE59283B1 (no)
IL (1)	IL81549A0 (no)
IT (1)	IT1213034B (no)
NO (1)	NO874241L (no)
NZ (1)	NZ219259A (no)
PH (1)	PH24445A (no)
WO (1)	WO1987005024A1 (no)
ZA (1)	ZA871032B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0348859A1 (en) *	1988-07-01	1990-01-03	MAGIS FARMACEUTICI S.p.A.	1,2-di-O-acyl glycero(DI)phosphate of L-carnitine and its derivatives, a process for their preparation and pharmaceutical formulations which contain them
IT1230140B (it) *	1989-05-03	1991-10-14	Fidia Spa	Derivati della serina, loro processo di preparazione e impiego in terapia umana
IT1231776B (it) *	1989-08-07	1991-12-21	Magis Farmaceutici	Processo per preparare i derivati acetilati della l alfa glicerofosforil serina.
IT1254471B (it) *	1992-02-27	1995-09-25	Magis Farmaceutici	Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento
IT1265647B1 (it) *	1992-11-18	1996-11-22	Farmin Srl	Composizione farmaceutiche topiche per le allergie respiratorie
JP6195949B2 (ja)	2016-02-26	2017-09-13	株式会社リケン	ピストンリング
CN108558937B (zh) *	2018-04-19	2019-05-24	厦门大学	一种L-α-甘油磷脂酰丝氨酸及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS55115824A (en) *	1979-02-28	1980-09-06	Nippon Shoji Kk	Remedy for clouding of consciousness and sensomobile disorder
IT1123142B (it) *	1979-09-14	1986-04-30	Lpb Ist Farm	Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative
DE3212387A1 (de) *	1982-04-02	1983-10-13	Bayer Ag, 5090 Leverkusen	Glycerinphosphatide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4624852A (en) *	1983-05-16	1986-11-25	Massachusetts Institute Of Technology	Process and composition for treating neurological disorders and aging
JPS6081193A (ja) *	1983-10-11	1985-05-09	Takeda Chem Ind Ltd	リン脂質
IT1212900B (it) *	1983-11-17	1989-11-30	Valle Francesco Della	Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
IT1199972B (it) *	1985-05-08	1989-01-05	Lpb Ist Farm	Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale

1986
- 1986-02-12 IT IT8619382A patent/IT1213034B/it active
1987
- 1987-02-12 ZA ZA871032A patent/ZA871032B/xx unknown
- 1987-02-12 WO PCT/EP1987/000068 patent/WO1987005024A1/en active IP Right Grant
- 1987-02-12 DE DE8787901055T patent/DE3775854D1/de not_active Expired - Fee Related
- 1987-02-12 US US07/112,000 patent/US4950776A/en not_active Expired - Fee Related
- 1987-02-12 IE IE36187A patent/IE59283B1/en not_active IP Right Cessation
- 1987-02-12 CA CA000529554A patent/CA1291766C/en not_active Expired - Lifetime
- 1987-02-12 EP EP87901055A patent/EP0256069B1/en not_active Expired - Lifetime
- 1987-02-12 PH PH34851A patent/PH24445A/en unknown
- 1987-02-12 JP JP62501166A patent/JPH0780775B2/ja not_active Expired - Lifetime
- 1987-02-12 AT AT87901055T patent/ATE71385T1/de not_active IP Right Cessation
- 1987-02-12 NZ NZ219259A patent/NZ219259A/xx unknown
- 1987-02-12 KR KR1019870700914A patent/KR940011187B1/ko not_active IP Right Cessation
- 1987-02-12 IL IL81549A patent/IL81549A0/xx not_active IP Right Cessation
- 1987-02-12 AU AU70250/87A patent/AU601403B2/en not_active Ceased
- 1987-02-12 HU HU871033A patent/HU199148B/hu not_active IP Right Cessation
- 1987-10-09 NO NO874241A patent/NO874241L/no unknown
- 1987-10-09 FI FI874450A patent/FI874450A/fi not_active IP Right Cessation
- 1987-10-12 DK DK532087A patent/DK169339B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
IT8619382A0 (it)	1986-02-12
IE59283B1 (en)	1994-02-09
DK532087D0 (da)	1987-10-12
ATE71385T1 (de)	1992-01-15
KR880700805A (ko)	1988-04-12
JPS63502893A (ja)	1988-10-27
NZ219259A (en)	1989-04-26
ZA871032B (en)	1987-08-04
CA1291766C (en)	1991-11-05
US4950776A (en)	1990-08-21
DE3775854D1 (de)	1992-02-20
IE870361L (en)	1987-08-12
EP0256069B1 (en)	1992-01-08
FI874450A0 (fi)	1987-10-09
NO874241L (no)	1987-12-09
FI874450A (fi)	1987-10-09
PH24445A (en)	1990-06-25
DK169339B1 (da)	1994-10-10
HUT47299A (en)	1989-02-28
HU199148B (en)	1990-01-29
IL81549A0 (en)	1987-09-16
DK532087A (da)	1987-10-12
JPH0780775B2 (ja)	1995-08-30
AU601403B2 (en)	1990-09-13
EP0256069A1 (en)	1988-02-24
KR940011187B1 (ko)	1994-11-26
AU7025087A (en)	1987-09-09
WO1987005024A1 (en)	1987-08-27
IT1213034B (it)	1989-12-07

Publication	Publication Date	Title
DE19375061I2 (de)	2008-11-20	Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
AU562938B2 (en)	1987-06-25	7, 10, 13, 16 docosatetraenoic acid composition
GR3019179T3 (en)	1996-06-30	Flupirtine in combination with antiparkinsonica against muscle bracing
NO874241D0 (no)	1987-10-09	Terapeutisk aktive salter.
DE58903964D1 (de)	1993-05-06	Fluessige orale formulierung.
DE3462688D1 (en)	1987-04-23	1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
DK284588A (da)	1988-11-27	Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
AU1621888A (en)	1988-11-04	Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
GR3005231T3 (no)	1993-05-24
DE69009765D1 (de)	1994-07-14	Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
IT8423800A0 (it)	1984-11-29	Procedimento di trattamento di stati ipotrofici nel bambino mediante somministrazioni di aspartato di arginina.
NO880639D0 (no)	1988-02-12	Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner.
MX9203508A (es)	1992-07-01	1,7-difenil-3-metilaza -7-ciano-8-metilnonano para usarse en el tratamiento de enfermedades.
IT8602913A0 (it)	1986-04-29	Metodo per l'isolamento protettivo di vitamine, e altre sostanze di facile alterazione chimica.
IT8723015A0 (it)	1987-12-15	Vite endoossea, da utilizzarsi nell'implantologia odontoiatrica.
SG13194G (en)	1994-06-10	Pharmaceutical composition for treating inflammation in the eye.
ATE70840T1 (de)	1992-01-15	Benzothiepino(5,4-c>pyridazin-verbindungen und ihre pharmazeutischen wirkungen.